Companion Diagnostic market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Companion Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Immunohistochemistry Molecular Diagnosis Segment by Application Oncology Cardiovascular Central Nervous System Virology Others By Company Roche Holdings Abbott Laboratories Thermo Fisher Scientific Agilent Technologies Merck Agendia Qiagen Myriad Genetics Advanced Cell Diagnostics Danaher Illumina, Inc By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA
1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Companion Diagnostic Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Immunohistochemistry 1.2.3 Molecular Diagnosis 1.3 Market by Application 1.3.1 Global Companion Diagnostic Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Oncology 1.3.3 Cardiovascular 1.3.4 Central Nervous System 1.3.5 Virology 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Companion Diagnostic Market Perspective (2017-2028) 2.2 Companion Diagnostic Growth Trends by Region 2.2.1 Companion Diagnostic Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Companion Diagnostic Historic Market Size by Region (2017-2022) 2.2.3 Companion Diagnostic Forecasted Market Size by Region (2023-2028) 2.3 Companion Diagnostic Market Dynamics 2.3.1 Companion Diagnostic Industry Trends 2.3.2 Companion Diagnostic Market Drivers 2.3.3 Companion Diagnostic Market Challenges 2.3.4 Companion Diagnostic Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Companion Diagnostic Players by Revenue 3.1.1 Global Top Companion Diagnostic Players by Revenue (2017-2022) 3.1.2 Global Companion Diagnostic Revenue Market Share by Players (2017-2022) 3.2 Global Companion Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Companion Diagnostic Revenue 3.4 Global Companion Diagnostic Market Concentration Ratio 3.4.1 Global Companion Diagnostic Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Revenue in 2021 3.5 Companion Diagnostic Key Players Head office and Area Served 3.6 Key Players Companion Diagnostic Product Solution and Service 3.7 Date of Enter into Companion Diagnostic Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Companion Diagnostic Breakdown Data by Type 4.1 Global Companion Diagnostic Historic Market Size by Type (2017-2022) 4.2 Global Companion Diagnostic Forecasted Market Size by Type (2023-2028) 5 Companion Diagnostic Breakdown Data by Application 5.1 Global Companion Diagnostic Historic Market Size by Application (2017-2022) 5.2 Global Companion Diagnostic Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Companion Diagnostic Market Size (2017-2028) 6.2 North America Companion Diagnostic Market Size by Type 6.2.1 North America Companion Diagnostic Market Size by Type (2017-2022) 6.2.2 North America Companion Diagnostic Market Size by Type (2023-2028) 6.2.3 North America Companion Diagnostic Market Share by Type (2017-2028) 6.3 North America Companion Diagnostic Market Size by Application 6.3.1 North America Companion Diagnostic Market Size by Application (2017-2022) 6.3.2 North America Companion Diagnostic Market Size by Application (2023-2028) 6.3.3 North America Companion Diagnostic Market Share by Application (2017-2028) 6.4 North America Companion Diagnostic Market Size by Country 6.4.1 North America Companion Diagnostic Market Size by Country (2017-2022) 6.4.2 North America Companion Diagnostic Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Companion Diagnostic Market Size (2017-2028) 7.2 Europe Companion Diagnostic Market Size by Type 7.2.1 Europe Companion Diagnostic Market Size by Type (2017-2022) 7.2.2 Europe Companion Diagnostic Market Size by Type (2023-2028) 7.2.3 Europe Companion Diagnostic Market Share by Type (2017-2028) 7.3 Europe Companion Diagnostic Market Size by Application 7.3.1 Europe Companion Diagnostic Market Size by Application (2017-2022) 7.3.2 Europe Companion Diagnostic Market Size by Application (2023-2028) 7.3.3 Europe Companion Diagnostic Market Share by Application (2017-2028) 7.4 Europe Companion Diagnostic Market Size by Country 7.4.1 Europe Companion Diagnostic Market Size by Country (2017-2022) 7.4.2 Europe Companion Diagnostic Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Companion Diagnostic Market Size (2017-2028) 8.2 Asia-Pacific Companion Diagnostic Market Size by Type 8.2.1 Asia-Pacific Companion Diagnostic Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Companion Diagnostic Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Companion Diagnostic Market Share by Type (2017-2028) 8.3 Asia-Pacific Companion Diagnostic Market Size by Application 8.3.1 Asia-Pacific Companion Diagnostic Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Companion Diagnostic Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Companion Diagnostic Market Share by Application (2017-2028) 8.4 Asia-Pacific Companion Diagnostic Market Size by Region 8.4.1 Asia-Pacific Companion Diagnostic Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Companion Diagnostic Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Companion Diagnostic Market Size (2017-2028) 9.2 Latin America Companion Diagnostic Market Size by Type 9.2.1 Latin America Companion Diagnostic Market Size by Type (2017-2022) 9.2.2 Latin America Companion Diagnostic Market Size by Type (2023-2028) 9.2.3 Latin America Companion Diagnostic Market Share by Type (2017-2028) 9.3 Latin America Companion Diagnostic Market Size by Application 9.3.1 Latin America Companion Diagnostic Market Size by Application (2017-2022) 9.3.2 Latin America Companion Diagnostic Market Size by Application (2023-2028) 9.3.3 Latin America Companion Diagnostic Market Share by Application (2017-2028) 9.4 Latin America Companion Diagnostic Market Size by Country 9.4.1 Latin America Companion Diagnostic Market Size by Country (2017-2022) 9.4.2 Latin America Companion Diagnostic Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Companion Diagnostic Market Size (2017-2028) 10.2 Middle East & Africa Companion Diagnostic Market Size by Type 10.2.1 Middle East & Africa Companion Diagnostic Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Companion Diagnostic Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Companion Diagnostic Market Share by Type (2017-2028) 10.3 Middle East & Africa Companion Diagnostic Market Size by Application 10.3.1 Middle East & Africa Companion Diagnostic Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Companion Diagnostic Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Companion Diagnostic Market Share by Application (2017-2028) 10.4 Middle East & Africa Companion Diagnostic Market Size by Country 10.4.1 Middle East & Africa Companion Diagnostic Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Companion Diagnostic Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Roche Holdings 11.1.1 Roche Holdings Company Details 11.1.2 Roche Holdings Business Overview 11.1.3 Roche Holdings Companion Diagnostic Introduction 11.1.4 Roche Holdings Revenue in Companion Diagnostic Business (2017-2022) 11.1.5 Roche Holdings Recent Developments 11.2 Abbott Laboratories 11.2.1 Abbott Laboratories Company Details 11.2.2 Abbott Laboratories Business Overview 11.2.3 Abbott Laboratories Companion Diagnostic Introduction 11.2.4 Abbott Laboratories Revenue in Companion Diagnostic Business (2017-2022) 11.2.5 Abbott Laboratories Recent Developments 11.3 Thermo Fisher Scientific 11.3.1 Thermo Fisher Scientific Company Details 11.3.2 Thermo Fisher Scientific Business Overview 11.3.3 Thermo Fisher Scientific Companion Diagnostic Introduction 11.3.4 Thermo Fisher Scientific Revenue in Companion Diagnostic Business (2017-2022) 11.3.5 Thermo Fisher Scientific Recent Developments 11.4 Agilent Technologies 11.4.1 Agilent Technologies Company Details 11.4.2 Agilent Technologies Business Overview 11.4.3 Agilent Technologies Companion Diagnostic Introduction 11.4.4 Agilent Technologies Revenue in Companion Diagnostic Business (2017-2022) 11.4.5 Agilent Technologies Recent Developments 11.5 Merck 11.5.1 Merck Company Details 11.5.2 Merck Business Overview 11.5.3 Merck Companion Diagnostic Introduction 11.5.4 Merck Revenue in Companion Diagnostic Business (2017-2022) 11.5.5 Merck Recent Developments 11.6 Agendia 11.6.1 Agendia Company Details 11.6.2 Agendia Business Overview 11.6.3 Agendia Companion Diagnostic Introduction 11.6.4 Agendia Revenue in Companion Diagnostic Business (2017-2022) 11.6.5 Agendia Recent Developments 11.7 Qiagen 11.7.1 Qiagen Company Details 11.7.2 Qiagen Business Overview 11.7.3 Qiagen Companion Diagnostic Introduction 11.7.4 Qiagen Revenue in Companion Diagnostic Business (2017-2022) 11.7.5 Qiagen Recent Developments 11.8 Myriad Genetics 11.8.1 Myriad Genetics Company Details 11.8.2 Myriad Genetics Business Overview 11.8.3 Myriad Genetics Companion Diagnostic Introduction 11.8.4 Myriad Genetics Revenue in Companion Diagnostic Business (2017-2022) 11.8.5 Myriad Genetics Recent Developments 11.9 Advanced Cell Diagnostics 11.9.1 Advanced Cell Diagnostics Company Details 11.9.2 Advanced Cell Diagnostics Business Overview 11.9.3 Advanced Cell Diagnostics Companion Diagnostic Introduction 11.9.4 Advanced Cell Diagnostics Revenue in Companion Diagnostic Business (2017-2022) 11.9.5 Advanced Cell Diagnostics Recent Developments 11.10 Danaher 11.10.1 Danaher Company Details 11.10.2 Danaher Business Overview 11.10.3 Danaher Companion Diagnostic Introduction 11.10.4 Danaher Revenue in Companion Diagnostic Business (2017-2022) 11.10.5 Danaher Recent Developments 11.11 Illumina, Inc 11.11.1 Illumina, Inc Company Details 11.11.2 Illumina, Inc Business Overview 11.11.3 Illumina, Inc Companion Diagnostic Introduction 11.11.4 Illumina, Inc Revenue in Companion Diagnostic Business (2017-2022) 11.11.5 Illumina, Inc Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
List of Tables Table 1. Global Companion Diagnostic Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Immunohistochemistry Table 3. Key Players of Molecular Diagnosis Table 4. Global Companion Diagnostic Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 5. Global Companion Diagnostic Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Companion Diagnostic Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Companion Diagnostic Market Share by Region (2017-2022) Table 8. Global Companion Diagnostic Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Companion Diagnostic Market Share by Region (2023-2028) Table 10. Companion Diagnostic Market Trends Table 11. Companion Diagnostic Market Drivers Table 12. Companion Diagnostic Market Challenges Table 13. Companion Diagnostic Market Restraints Table 14. Global Companion Diagnostic Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Companion Diagnostic Revenue Share by Players (2017-2022) Table 16. Global Top Companion Diagnostic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic as of 2021) Table 17. Ranking of Global Top Companion Diagnostic Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Companion Diagnostic Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Companion Diagnostic Product Solution and Service Table 21. Date of Enter into Companion Diagnostic Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Companion Diagnostic Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Companion Diagnostic Revenue Market Share by Type (2017-2022) Table 25. Global Companion Diagnostic Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Companion Diagnostic Revenue Market Share by Type (2023-2028) Table 27. Global Companion Diagnostic Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Companion Diagnostic Revenue Share by Application (2017-2022) Table 29. Global Companion Diagnostic Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Companion Diagnostic Revenue Share by Application (2023-2028) Table 31. North America Companion Diagnostic Market Size by Type (2017-2022) & (US$ Million) Table 32. North America Companion Diagnostic Market Size by Type (2023-2028) & (US$ Million) Table 33. North America Companion Diagnostic Market Size by Application (2017-2022) & (US$ Million) Table 34. North America Companion Diagnostic Market Size by Application (2023-2028) & (US$ Million) Table 35. North America Companion Diagnostic Market Size by Country (2017-2022) & (US$ Million) Table 36. North America Companion Diagnostic Market Size by Country (2023-2028) & (US$ Million) Table 37. Europe Companion Diagnostic Market Size by Type (2017-2022) & (US$ Million) Table 38. Europe Companion Diagnostic Market Size by Type (2023-2028) & (US$ Million) Table 39. Europe Companion Diagnostic Market Size by Application (2017-2022) & (US$ Million) Table 40. Europe Companion Diagnostic Market Size by Application (2023-2028) & (US$ Million) Table 41. Europe Companion Diagnostic Market Size by Country (2017-2022) & (US$ Million) Table 42. Europe Companion Diagnostic Market Size by Country (2023-2028) & (US$ Million) Table 43. Asia Pacific Companion Diagnostic Market Size by Type (2017-2022) & (US$ Million) Table 44. Asia Pacific Companion Diagnostic Market Size by Type (2023-2028) & (US$ Million) Table 45. Asia Pacific Companion Diagnostic Market Size by Application (2017-2022) & (US$ Million) Table 46. Asia Pacific Companion Diagnostic Market Size by Application (2023-2028) & (US$ Million) Table 47. Asia Pacific Companion Diagnostic Market Size by Region (2017-2022) & (US$ Million) Table 48. Asia Pacific Companion Diagnostic Market Size by Region (2023-2028) & (US$ Million) Table 49. Latin America Companion Diagnostic Market Size by Type (2017-2022) & (US$ Million) Table 50. Latin America Companion Diagnostic Market Size by Type (2023-2028) & (US$ Million) Table 51. Latin America Companion Diagnostic Market Size by Application (2017-2022) & (US$ Million) Table 52. Latin America Companion Diagnostic Market Size by Application (2023-2028) & (US$ Million) Table 53. Latin America Companion Diagnostic Market Size by Country (2017-2022) & (US$ Million) Table 54. Latin America Companion Diagnostic Market Size by Country (2023-2028) & (US$ Million) Table 55. Middle East and Africa Companion Diagnostic Market Size by Type (2017-2022) & (US$ Million) Table 56. Middle East and Africa Companion Diagnostic Market Size by Type (2023-2028) & (US$ Million) Table 57. Middle East and Africa Companion Diagnostic Market Size by Application (2017-2022) & (US$ Million) Table 58. Middle East and Africa Companion Diagnostic Market Size by Application (2023-2028) & (US$ Million) Table 59. Middle East and Africa Companion Diagnostic Market Size by Country (2017-2022) & (US$ Million) Table 60. Middle East and Africa Companion Diagnostic Market Size by Country (2023-2028) & (US$ Million) Table 61. Roche Holdings Company Details Table 62. Roche Holdings Business Overview Table 63. Roche Holdings Companion Diagnostic Product Table 64. Roche Holdings Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million) Table 65. Roche Holdings Recent Developments Table 66. Abbott Laboratories Company Details Table 67. Abbott Laboratories Business Overview Table 68. Abbott Laboratories Companion Diagnostic Product Table 69. Abbott Laboratories Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million) Table 70. Abbott Laboratories Recent Developments Table 71. Thermo Fisher Scientific Company Details Table 72. Thermo Fisher Scientific Business Overview Table 73. Thermo Fisher Scientific Companion Diagnostic Product Table 74. Thermo Fisher Scientific Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million) Table 75. Thermo Fisher Scientific Recent Developments Table 76. Agilent Technologies Company Details Table 77. Agilent Technologies Business Overview Table 78. Agilent Technologies Companion Diagnostic Product Table 79. Agilent Technologies Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million) Table 80. Agilent Technologies Recent Developments Table 81. Merck Company Details Table 82. Merck Business Overview Table 83. Merck Companion Diagnostic Product Table 84. Merck Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million) Table 85. Merck Recent Developments Table 86. Agendia Company Details Table 87. Agendia Business Overview Table 88. Agendia Companion Diagnostic Product Table 89. Agendia Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million) Table 90. Agendia Recent Developments Table 91. Qiagen Company Details Table 92. Qiagen Business Overview Table 93. Qiagen Companion Diagnostic Product Table 94. Qiagen Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million) Table 95. Qiagen Recent Developments Table 96. Myriad Genetics Company Details Table 97. Myriad Genetics Business Overview Table 98. Myriad Genetics Companion Diagnostic Product Table 99. Myriad Genetics Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million) Table 100. Myriad Genetics Recent Developments Table 101. Advanced Cell Diagnostics Company Details Table 102. Advanced Cell Diagnostics Business Overview Table 103. Advanced Cell Diagnostics Companion Diagnostic Product Table 104. Advanced Cell Diagnostics Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million) Table 105. Advanced Cell Diagnostics Recent Developments Table 106. Danaher Company Details Table 107. Danaher Business Overview Table 108. Danaher Companion Diagnostic Product Table 109. Danaher Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million) Table 110. Danaher Recent Developments Table 111. Illumina, Inc Company Details Table 112. Illumina, Inc Business Overview Table 113. Illumina, Inc Companion Diagnostic Product Table 114. Illumina, Inc Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million) Table 115. Illumina, Inc Recent Developments Table 116. Research Programs/Design for This Report Table 117. Key Data Information from Secondary Sources Table 118. Key Data Information from Primary Sources List of Figures Figure 1. Global Companion Diagnostic Market Share by Type: 2021 VS 2028 Figure 2. Immunohistochemistry Features Figure 3. Molecular Diagnosis Features Figure 4. Global Companion Diagnostic Market Share by Application: 2021 VS 2028 Figure 5. Oncology Case Studies Figure 6. Cardiovascular Case Studies Figure 7. Central Nervous System Case Studies Figure 8. Virology Case Studies Figure 9. Others Case Studies Figure 10. Companion Diagnostic Report Years Considered Figure 11. Global Companion Diagnostic Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 12. Global Companion Diagnostic Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Companion Diagnostic Market Share by Region: 2021 VS 2028 Figure 14. Global Companion Diagnostic Market Share by Players in 2021 Figure 15. Global Top Companion Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic as of 2021) Figure 16. The Top 10 and 5 Players Market Share by Companion Diagnostic Revenue in 2021 Figure 17. North America Companion Diagnostic Market Size YoY (2017-2028) & (US$ Million) Figure 18. North America Companion Diagnostic Market Size Market Share by Type (2017-2028) Figure 19. North America Companion Diagnostic Market Size Market Share by Application (2017-2028) Figure 20. North America Companion Diagnostic Market Size Share by Country (2017-2028) Figure 21. United States Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Canada Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Companion Diagnostic Market Size YoY (2017-2028) & (US$ Million) Figure 24. Europe Companion Diagnostic Market Size Market Share by Type (2017-2028) Figure 25. Europe Companion Diagnostic Market Size Market Share by Application (2017-2028) Figure 26. Europe Companion Diagnostic Market Size Share by Country (2017-2028) Figure 27. Germany Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. France Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. U.K. Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Italy Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Russia Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Nordic Countries Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Asia-Pacific Companion Diagnostic Market Size YoY (2017-2028) & (US$ Million) Figure 34. Asia Pacific Companion Diagnostic Market Size Market Share by Type (2017-2028) Figure 35. Asia Pacific Companion Diagnostic Market Size Market Share by Application (2017-2028) Figure 36. Asia Pacific Companion Diagnostic Market Size Share by Region (2017-2028) Figure 37. China Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Japan Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. South Korea Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Southeast Asia Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. India Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Australia Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 43. Latin America Companion Diagnostic Market Size YoY (2017-2028) & (US$ Million) Figure 44. Latin America Companion Diagnostic Market Size Market Share by Type (2017-2028) Figure 45. Latin America Companion Diagnostic Market Size Market Share by Application (2017-2028) Figure 46. Latin America Companion Diagnostic Market Size Share by Country (2017-2028) Figure 47. Mexico Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 48. Brazil Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 49. Middle East & Africa Companion Diagnostic Market Size YoY (2017-2028) & (US$ Million) Figure 50. Middle East and Africa Companion Diagnostic Market Size Market Share by Type (2017-2028) Figure 51. Middle East and Africa Companion Diagnostic Market Size Market Share by Application (2017-2028) Figure 52. Middle East and Africa Companion Diagnostic Market Size Share by Country (2017-2028) Figure 53. Turkey Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 54. Saudi Arabia Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 55. UAE Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 56. Roche Holdings Revenue Growth Rate in Companion Diagnostic Business (2017-2022) Figure 57. Abbott Laboratories Revenue Growth Rate in Companion Diagnostic Business (2017-2022) Figure 58. Thermo Fisher Scientific Revenue Growth Rate in Companion Diagnostic Business (2017-2022) Figure 59. Agilent Technologies Revenue Growth Rate in Companion Diagnostic Business (2017-2022) Figure 60. Merck Revenue Growth Rate in Companion Diagnostic Business (2017-2022) Figure 61. Agendia Revenue Growth Rate in Companion Diagnostic Business (2017-2022) Figure 62. Qiagen Revenue Growth Rate in Companion Diagnostic Business (2017-2022) Figure 63. Myriad Genetics Revenue Growth Rate in Companion Diagnostic Business (2017-2022) Figure 64. Advanced Cell Diagnostics Revenue Growth Rate in Companion Diagnostic Business (2017-2022) Figure 65. Danaher Revenue Growth Rate in Companion Diagnostic Business (2017-2022) Figure 66. Illumina, Inc Revenue Growth Rate in Companion Diagnostic Business (2017-2022) Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed